Bioenergetics & ETC

Bioenergetics

Part 1 of 4 — Free Energy, ATP & Energy Coupling

Gibbs Free Energy Decides Direction

$\Delta G = \Delta H - T\Delta S$

• $\Delta G < 0$: exergonic, spontaneous as written (says nothing about speed).
• $\Delta G > 0$: endergonic, nonspontaneous; needs coupling to proceed.
• $\Delta G = 0$: equilibrium — for a cell, equilibrium is death; metabolism runs on maintained disequilibrium.

Standard vs. Actual Free Energy

$\Delta G = \Delta G^{\circ\prime} + RT\ln Q$

$\Delta G^{\circ\prime} = -RT\ln K_{eq}$

$\Delta G^{\circ\prime}$ is measured at biochemical standard state (1 M everything, pH 7). Real cellular concentrations set $Q$, and $Q$ can flip the sign: several glycolytic reactions with positive $\Delta G^{\circ\prime}$ run forward in vivo because products are constantly removed (low $Q$). Conversely, a reaction with hugely negative $\Delta G^{\circ\prime}$ is effectively irreversible in the cell — these are the regulated control points.

Why ATP Is the Energy Currency

ATP hydrolysis to ADP + P$_i$ has $\Delta G^{\circ\prime} \approx -30.5$ kJ/mol (about −7.3 kcal/mol); in the cell, with concentrations far from standard, the actual value is closer to −50 kJ/mol. The payout comes from:

• Charge repulsion relief: four closely spaced negative charges separate.
• Resonance stabilization of the released phosphate.
• Solvation: products are hydrated better than ATP.

The Phosphoryl-Transfer Ladder

ATP sits mid-ladder on purpose: high-energy donors above it (PEP, 1,3-BPG) can phosphorylate ADP (substrate-level phosphorylation), and ATP in turn can phosphorylate acceptors below it (glucose, fructose-6-P). Creatine phosphate is muscle's rapid ATP buffer.

Energy Coupling

An endergonic step is driven by pairing it with an exergonic one sharing a common intermediate — free energies add:

Glutamate + NH$_3$ → glutamine has $\Delta G^{\circ\prime} = +14$ kJ/mol. Coupled to ATP hydrolysis (−30.5): net $\approx -16$ kJ/mol, spontaneous. The mechanism is a phosphorylated intermediate (glutamyl-phosphate), not "heat from ATP."

Free Energy & ATP 🎯

Key Takeaways — Part 1

• $\Delta G$ decides direction; enzymes change rate only. $\Delta G = \Delta G^{\circ\prime} + RT\ln Q$; concentrations can flip the sign
• $\Delta G^{\circ\prime} = -RT\ln K_{eq}$: negative means $K_{eq} > 1$
• ATP hydrolysis ~−30.5 kJ/mol standard, ~−50 kJ/mol in vivo; energy from charge relief, resonance, solvation — NOT from "breaking a bond"
• Transfer ladder: PEP > 1,3-BPG > creatine-P > ATP > G6P; higher can phosphorylate lower
• Coupling = shared chemical intermediate; free energies of coupled steps add

Worked Examples — Free-Energy Reasoning

Question: Glucose + P$_i$ → glucose-6-phosphate has $\Delta G^{\circ\prime} = +13.8$ kJ/mol. What is the net standard free energy when hexokinase couples this to ATP hydrolysis ($\Delta G^{\circ\prime} = -30.5$ kJ/mol), and why does the coupled reaction actually work mechanistically?

Solution:

1. Sum the two: $+13.8 + (-30.5) = -16.7$ kJ/mol — spontaneous.
2. Mechanistically, hexokinase transfers the $\gamma$-phosphate of ATP DIRECTLY to glucose in one active site; the "two reactions" never occur separately.
3. The common intermediate (the transferred phosphoryl group) is what makes the free energies additive.

MCAT Strategy: Coupled reactions are just added equations — cancel species appearing on both sides, add the $\Delta G^{\circ\prime}$ values.

Question: For an isomerization, $K_{eq} = 0.1$ at 37 degrees C. Is $\Delta G^{\circ\prime}$ positive or negative, and roughly how large? ($RT \approx 2.6$ kJ/mol at 310 K; $\ln 10 \approx 2.3$)

Solution:

1. $K_{eq} < 1$ means reactants favored: $\Delta G^{\circ\prime} > 0$.
2. $\Delta G^{\circ\prime} = -RT\ln K_{eq} = -2.6 \times \ln(0.1) = -2.6 \times (-2.3) \approx +6$ kJ/mol.
3. Modest positive values like this are routinely overcome in vivo by concentration effects (e.g., glycolysis' triose phosphate isomerase step, about +7.5 kJ/mol).

MCAT Strategy: Each factor of 10 in $K_{eq}$ corresponds to roughly 6 kJ/mol (1.4 kcal/mol) at body temperature — a fast mental conversion the exam rewards.

Question: The combustion of glucose has $\Delta G^{\circ\prime} \approx -2870$ kJ/mol, yet a bowl of sugar is stable in air for years. A student concludes the reaction must be endergonic at room temperature. What is wrong with this reasoning, and what do cells do about it?

Solution:

1. $\Delta G$ addresses THERMODYNAMICS (direction and extent), not KINETICS (rate). Glucose oxidation is highly exergonic but has an enormous activation barrier — it is kinetically stable.
2. Cells lower the barrier with enzymes and, crucially, release the energy in many small controlled steps, capturing portions as ATP and reduced carriers rather than as one burst of heat.
3. The student conflated "doesn't happen quickly" with "not spontaneous."

MCAT Strategy: "Spontaneous" = thermodynamically downhill, timescale unspecified. Any answer choice inferring rate from $\Delta G$ (or equilibrium shift from an enzyme) is wrong.

Bioenergetics

Part 2 of 4 — Redox Carriers, PDH & the Citric Acid Cycle

Biological Redox: Follow the Electrons

Oxidation = losing electrons (often losing H, gaining O); reduction = gaining electrons. Catabolism strips electrons from fuel and loads them onto mobile carriers:

NADH is catabolic cash; NADPH is anabolic credit. The MCAT loves this division of labor.

Pyruvate Dehydrogenase (PDH): The Gateway

In the mitochondrial matrix, the PDH complex performs oxidative decarboxylation:

Pyruvate + CoA + NAD$^+$ → acetyl-CoA + CO$_2$ + NADH

Five cofactors ("Tender Loving Care For Nancy"): TPP (thiamine/B1), Lipoic acid, CoA (pantothenate/B5), FAD (B2), NAD$^+$ (B3). Regulation:

• PDH kinase phosphorylates and INACTIVATES PDH; the kinase is stimulated by NADH, acetyl-CoA, and ATP (products signal "enough").
• PDH phosphatase (activated by Ca$^{2+}$, and by insulin in adipose) removes the phosphate, reactivating PDH.
• This step is irreversible — the reason carbohydrate carbon, once in acetyl-CoA, cannot make new glucose.

The Citric Acid Cycle (One Turn, One Acetyl-CoA)

Acetyl-CoA (2C) + oxaloacetate (4C) → citrate (6C) → ... → oxaloacetate regenerated.

Per turn: 3 NADH, 1 FADH$_2$, 1 GTP (succinyl-CoA synthetase — substrate-level), 2 CO$_2$ released.

The Cycle Is a Hub, Not Just a Furnace

Intermediates are siphoned for biosynthesis (citrate → fatty acids; $\alpha$-KG → glutamate; succinyl-CoA → heme; OAA → aspartate, glucose). Anaplerotic reactions refill the pool — chiefly pyruvate carboxylase (pyruvate + CO$_2$ + ATP → OAA, biotin-dependent, activated by acetyl-CoA).

Oxygen connection: the cycle uses no O$_2$ directly, yet halts under anaerobic conditions because NADH accumulates and NAD$^+$ runs out — the ETC (which needs O$_2$) is what reoxidizes the carriers.

Carriers, PDH & the TCA Cycle 🎯

Key Takeaways — Part 2

• NADH/FADH$_2$ feed the ETC (catabolism); NADPH powers biosynthesis and glutathione (anabolism) — never interchange them
• PDH: pyruvate → acetyl-CoA + CO$_2$ + NADH; 5 cofactors (TPP, lipoate, CoA, FAD, NAD$^+$); phosphorylation turns it OFF; irreversible
• Per acetyl-CoA: 3 NADH + 1 FADH$_2$ + 1 GTP + 2 CO$_2$; isocitrate DH is rate-limiting (ADP on, ATP/NADH off)
• Succinate dehydrogenase doubles as Complex II
• Cycle needs NAD$^+$ regenerated by the ETC → indirectly O$_2$-dependent; anaplerosis (pyruvate carboxylase) refills siphoned intermediates

• Low-yield extras: succinate that builds up in SDH-deficient tumors acts as an "oncometabolite" (stabilizes HIF); PDH kinase phosphorylates the E1 subunit

Worked Examples — Tracing Carbons & Regulation

Question: Glucose is labeled with $^{14}C$ at C-1. After glycolysis, the label appears on pyruvate's methyl carbon (C-3). Is the labeled carbon released as CO$_2$ by PDH?

Solution:

1. PDH decarboxylates pyruvate's CARBOXYL carbon (C-1 of pyruvate), not the methyl carbon.
2. The methyl label therefore enters acetyl-CoA (as part of the acetyl group's methyl carbon) and is NOT released by PDH.
3. It also survives the first turn of the TCA cycle: the two CO$_2$ molecules released in a given turn come from carbons that entered as part of oxaloacetate in that turn, not from the incoming acetyl group (label emerges in later turns).

MCAT Strategy: For label questions, track which specific carbon each decarboxylation removes — PDH removes pyruvate's carboxyl carbon, and the acetyl carbons are not lost in their first TCA turn.

Question: A tumor cell line carries loss-of-function mutations in succinate dehydrogenase. Which metabolite accumulates, and what happens to FADH$_2$-derived electron flow?

Solution:

1. SDH catalyzes succinate → fumarate; loss of function means succinate accumulates.
2. SDH IS Complex II — the same protein oxidizes succinate and passes electrons to CoQ. Its loss removes that entry point into the ETC.
3. NADH-linked (Complex I) electron flow continues, so the cell is not fully ETC-dead, but succinate oxidation is blocked.

MCAT Strategy: Any question linking the TCA cycle and the ETC through one enzyme is about succinate dehydrogenase — the only enzyme in both.

• Example 2 aside: in SDH-deficient tumors the accumulated succinate acts as an "oncometabolite" — it stabilizes the hypoxia factor HIF and alters signaling.

Question: Isolated mitochondria are incubated with pyruvate. Adding dichloroacetate (an inhibitor of PDH kinase) increases acetyl-CoA production. Explain, and predict the effect of adding high Ca$^{2+}$ instead.

Solution:

1. PDH kinase phosphorylates PDH → inactive. Inhibiting the kinase keeps PDH dephosphorylated and ACTIVE, so flux to acetyl-CoA rises — consistent with the observation.
2. Ca$^{2+}$ activates PDH phosphatase, which removes inhibitory phosphates: also MORE active PDH, same direction of effect. (This is how contracting muscle couples Ca$^{2+}$ signaling to fuel oxidation.)
3. Both manipulations converge on the phosphorylation state of PDH.

MCAT Strategy: For any "kinase of the kinase" logic, write the chain out with arrows and signs; an inhibitor of an inhibitor is an activator.

• Example 3 aside: the subunit that PDH kinase phosphorylates is E1, the complex's pyruvate-decarboxylating component.

Bioenergetics

Part 3 of 4 — Electron Transport & Oxidative Phosphorylation

The Chain: Four Complexes, Two Mobile Carriers

Electrons flow down an electrochemical staircase in the inner mitochondrial membrane, from carriers with more negative reduction potential toward O$_2$ (the most positive):

Because FADH$_2$ enters at Complex II (no pumping), its electrons drive fewer proton translocations: ~2.5 ATP per NADH vs. ~1.5 ATP per FADH$_2$.

Chemiosmosis

Proton pumping creates a proton-motive force across the inner membrane — part concentration gradient ($\Delta$pH, matrix alkaline) and part electrical potential ($\Delta\psi$, matrix negative). Protons flow back through ATP synthase (F$_o$ membrane channel spins the rotor; F$_1$ catalytic heads make ATP). ETC and ATP synthesis are coupled: block one and the other stalls.

Inhibitors & Uncouplers — Know the Map

The uncoupler signature: oxygen consumption UP, ATP synthesis DOWN, temperature UP. Inhibitors stop O$_2$ use; uncouplers accelerate it.

Getting Cytosolic NADH Inside: The Shuttles

Glycolytic NADH is cytosolic, and the inner membrane is impermeable to NADH.

• Malate-aspartate shuttle (heart, liver): NADH → matrix NADH → Complex I (~2.5 ATP).
• Glycerol-3-phosphate shuttle (muscle, brain): NADH → FADH$_2$ on the inner membrane → CoQ (~1.5 ATP). Faster but less efficient.

This shuttle choice is why total ATP per glucose is quoted as a range (~30-32) rather than a single number.

ETC & Oxidative Phosphorylation 🎯

Key Takeaways — Part 3

• Electron path: NADH → I → CoQ → III → cyt c → IV → O$_2$; FADH$_2$ enters at II (no pumping) → ~1.5 vs ~2.5 ATP
• Proton-motive force = $\Delta$pH + $\Delta\psi$ across the INNER membrane; ATP synthase (F$_o$F$_1$) is a rotary motor
• Inhibitor map: rotenone I, antimycin A III, CN/CO/azide IV, oligomycin ATP synthase
• Uncouplers (DNP, thermogenin): O$_2$ consumption UP, ATP DOWN, heat UP — opposite O$_2$ signature from inhibitors
• Shuttles for cytosolic NADH: malate-aspartate (keeps NADH value) vs. glycerol-3-phosphate (drops to FADH$_2$ value)

• Low-yield extras: antimycin A acts at Complex III's Qi site, the matrix-facing quinone-binding site of the Q cycle

Worked Examples — ETC Experiments

Question: In poisoned mitochondria, NADH, CoQ, and Complex III are all found fully REDUCED, while cytochrome c and Complex IV are fully OXIDIZED. Where is the block?

Solution:

1. Everything UPSTREAM of a block backs up in the reduced state (electrons pile up); everything downstream drains to the oxidized state.
2. The reduced/oxidized boundary lies between Complex III and cytochrome c.
3. The inhibitor blocks electron transfer from Complex III to cytochrome c — the behavior of antimycin A, a Complex III inhibitor.

MCAT Strategy: "Reduced before, oxidized after" — find the boundary and you have found the inhibitor's target. This is the ETC's version of a dammed river.

• Example 1 aside: within Complex III, antimycin A binds the Q cycle's matrix-facing quinone site (Qi), stalling electron flow through the complex.

Question: Severe salicylate toxicity produces hyperthermia, increased O$_2$ consumption, and falling ATP despite abundant fuel. Which single mechanism explains all three findings?

Solution:

1. Salicylates at toxic doses act as protonophore UNCOUPLERS: they shuttle H$^+$ across the inner membrane, dissipating the gradient.
2. Electron transport races to rebuild the gradient → O$_2$ consumption rises; the gradient's energy is lost as heat → hyperthermia.
3. No gradient reaches ATP synthase → ATP synthesis falls even though the ETC is running at maximum.

MCAT Strategy: The triad "more O$_2$, less ATP, more heat" always means uncoupling — the same physiology as brown-fat thermogenin, just pathological.

Question: A liver cell oxidizes one cytosolic NADH via the malate-aspartate shuttle; a muscle cell oxidizes one via the glycerol-3-phosphate shuttle; a third NADH is generated inside the matrix by isocitrate dehydrogenase. Rank the ATP yields.

Solution:

1. Matrix NADH (isocitrate DH): enters Complex I directly → ~2.5 ATP.
2. Liver cytosolic NADH: malate-aspartate shuttle regenerates NADH INSIDE the matrix → also ~2.5 ATP.
3. Muscle cytosolic NADH: glycerol-3-P shuttle delivers electrons via FAD to CoQ → ~1.5 ATP.
4. Ranking: matrix = liver shuttle > muscle shuttle.

MCAT Strategy: Ask ONE question about any NADH: do its electrons reach Complex I or skip to CoQ? That single fact sets the yield.

Bioenergetics

Part 4 of 4 — ATP Accounting, Energy States & MCAT Integration

The Full Ledger for One Glucose (Aerobic)

Oxidative phosphorylation converts carriers at ~2.5 ATP/NADH and ~1.5 ATP/FADH$_2$:

• 8 matrix NADH × 2.5 = 20
• 2 FADH$_2$ × 1.5 = 3
• 2 cytosolic NADH × 2.5 (malate-aspartate) or × 1.5 (glycerol-3-P) = 5 or 3
• Plus 4 direct (2 ATP + 2 GTP)

Total ~30-32 ATP per glucose. Anaerobic glycolysis alone: 2 ATP — a 15-fold difference that explains why oxygen debt, fast-twitch fatigue, and the Warburg effect all matter.

Energy State Sensing

• High AMP (via adenylate kinase: 2 ADP $\rightleftharpoons$ ATP + AMP) is the cell's low-fuel alarm; it activates AMPK, which switches ON catabolism (glycolysis, fatty acid oxidation) and OFF biosynthesis.
• ATP/citrate/NADH high = fed, energy-rich signals that inhibit PFK-1, isocitrate DH, PDH.
• Creatine phosphate buffers ATP over seconds; glycogen over minutes; fat over days.

Fed vs. Fasting Energy Flow (Preview of Metabolic Integration)

Passage Skills: Oxygen Electrode & Respirometry Experiments

MCAT bioenergetics passages often show O$_2$ consumption traces of isolated mitochondria:

1. Substrate added (e.g., succinate or malate): slow O$_2$ use (limited by ADP availability).
2. ADP added: O$_2$ use accelerates — proof that respiration is coupled to phosphorylation.
3. ADP exhausted: slows again.
4. Oligomycin: O$_2$ use stops (synthase blocked, gradient maxed).
5. Uncoupler (DNP): O$_2$ use surges to maximum with NO ATP made (uncoupled).

• Lab labels: ADP-stimulated respiration is called "state 3" and the slower rate after ADP runs out "state 4"; FCCP is a laboratory uncoupler used like DNP.

Also expect the P/O ratio (ATP made per oxygen atom reduced): higher for NADH-linked substrates (malate/glutamate) than for succinate — because of Complex I.

ATP Accounting & Integration 🎯

Key Takeaways — Part 4

• Glucose ledger: 2 ATP + 2 GTP direct, 10 NADH + 2 FADH$_2$ as carriers → ~30-32 ATP total; anaerobic = 2
• Yield range comes from the cytosolic-NADH shuttle choice (~2.5 vs ~1.5 each)
• AMP (amplified by adenylate kinase) → AMPK = low-energy alarm; ATP/NADH/citrate = abundance signals
• Respirometry: ADP addition speeds O$_2$ use (coupling), oligomycin stops it, uncoupler maximizes it without ATP
• P/O ratio: NADH-linked substrates > succinate (Complex I pumping); fasting turns PDH off to spare gluconeogenic carbon

• Low-yield extras: respirometry jargon — ADP-stimulated respiration is "state 3", the post-ADP rate is "state 4"; FCCP is a lab uncoupler that behaves like DNP

Worked Examples — Quantitative Integration

Question: Compute the ATP yield from one glucose fully oxidized in a muscle cell using the glycerol-3-phosphate shuttle (use 2.5/NADH and 1.5/FADH$_2$).

Solution:

1. Direct: 2 ATP (glycolysis) + 2 GTP (TCA) = 4
2. Matrix NADH: 2 (PDH) + 6 (TCA) = 8 → $8 \times 2.5 = 20$
3. FADH$_2$: 2 (TCA) → $2 \times 1.5 = 3$
4. Cytosolic NADH: 2 via glycerol-3-P shuttle → counted at FADH$_2$ value: $2 \times 1.5 = 3$
5. Total: $4 + 20 + 3 + 3 = 30$ ATP (32 with the malate-aspartate shuttle: the 2 cytosolic NADH count as $2 \times 2.5 = 5$).

MCAT Strategy: Memorize the carrier inventory (10 NADH, 2 FADH$_2$, 4 direct) and just adjust the two cytosolic NADH for the shuttle in play.

Question: A trace shows: malate added (slow O$_2$ decline) → ADP added (fast decline) → plateau → compound X added (O$_2$ decline stops) → compound Y added (fastest decline of all). Identify X and Y.

Solution:

1. The ADP response and later plateau are normal coupled respiration: fast while ADP is available, slow again once it is used up.
2. X halts O$_2$ consumption with substrate still present: it blocks either the chain or the synthase. Because Y subsequently RESTORES rapid O$_2$ use, the chain must be intact — so X is oligomycin (ATP synthase block; gradient back-pressure stops electron flow).
3. Y bypasses the synthase by collapsing the gradient: an uncoupler (such as DNP). Maximum electron flow, zero ATP.

MCAT Strategy: An uncoupler is the only agent that INCREASES O$_2$ consumption after oligomycin; if Y had been cyanide, the trace would have stayed flat.

Question: Explain why a 100 m sprinter accumulates lactate while a marathoner mostly does not, in bioenergetic terms.

Solution:

1. Sprint: ATP demand exceeds oxidative capacity's ramp-up. Creatine phosphate covers seconds; then anaerobic glycolysis dominates — fast ATP (2/glucose) with NAD$^+$ regenerated by lactate dehydrogenase → lactate accumulates.
2. Marathon: steady-state demand sits within oxidative phosphorylation's capacity; muscle burns glucose and increasingly fatty acids (~106 ATP per palmitate), and NADH is reoxidized by the ETC, not LDH.
3. The sprinter trades efficiency for POWER (ATP per second); the marathoner trades power for efficiency (ATP per gram fuel).

MCAT Strategy: Frame exercise questions as rate vs. yield: glycolysis is low-yield but fast and O$_2$-independent; oxidation is high-yield but O$_2$- and time-limited.